(Q43179194)

15 November 2017

title

Medical oncology: treatment and management of malignant gliomas (English)

1 reference

15 November 2017

1 reference

3

Jeremy N Rich

1 reference

15 November 2017

Deric M Park

1

1 reference

15 November 2017

Sith Sathornsumetee

series ordinal

2

1 reference

15 November 2017

language of work or name

English

0 references

publication date

1 February 2010

1 reference

Nature Reviews Clinical Oncology

15 November 2017

published in

1 reference

15 November 2017

volume

7

1 reference

15 November 2017

issue

2

1 reference

15 November 2017

page(s)

75-77

1 reference

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

15 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.221

Bevacizumab plus irinotecan in recurrent glioblastoma multiforme

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.221

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.221

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.221

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.221

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.221

IDH1 and IDH2 mutations in gliomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.221

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.221

Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.221

Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.221

10.1038/NRCLINONC.2009.221

31 March 2020

Identifiers

DOI

1 reference

15 November 2017

1 reference